Botox® is a prescription medicine for the treatment of frown lines , horizontal forehead lines and crow’s feet round the eyes. Botox® has risks and benefits. Ask your doctor if Botox is right for you. If you have side effects, see your doctor. You will need to pay for Botox® and clinic fees will apply. For details on precautions & side effects consult your healthcare professional or the Consumer Medicine Information (CMI) at www.medsafe.govt.nz . Botox® treatment lasts about 4 months and further courses of treatment may be necessary. Should only be administered by trained medical professionals. (contains botulinum toxin A 50,100 & 200 units) Allergan (NZ) Limited, Auckland.
TEOSYAL RHA ® 1, TEOSYAL RHA ® 2, TEOSYAL RHA ® 3, TEOSYAL RHA ® 4, TEOSYAL ® PURESENSE REDENSITY 1, TEOSYAL ® PURESENSE REDENSITY 2, TEOSYAL PURESENSE KISS ® , TEOSYAL® PURESENSE GLOBAL ACTION, TEOSYAL ® PURESENSE DEEP LINES, TEOSYAL ® PURESENSE ULTIMATE and TEOSYAL ® PURESENSE ULTRA DEEP TEOSYAL KISS ® , RHA KISS ® , TEOSYAL ® MESO, TEOSYAL ® GLOBAL ACTION, TEOSYAL ® DEEP LINES, , TEOSYAL ® ULTIMATE and TEOSYAL ® ULTRA DEEP are trademark of the firm TEOXANE SA. These products are gel that contains hyaluronic acid, and 0.3% by weight of lidocaine hydrochloride They are class III medical devices. Caution for people on blood thinning medicines. Local side effects: inflammatory reactions (redness, oedema, pain at the point of injection), haematomas, itching, temporary loss of sensitivity around the injected area, disorders of pigmentation in skin and hair, abscesses, indurations, nodules (possibly ranulomas). General manifestations: immediate hypersensitivity up to anaphylactic shock, migration of the implant. Rare but serious adverse events associated with the intravascular injection of soft tissue fillers in the face have been reported and include temporary or permanent vision impairment or blindness, skin necrosis and stroke. Lasts 9 -12 months. Please consult your doctor pharmacist for more information. Please refer to instructions for use, local distributor. Healthcare Logistics, Auckland.
Dysport® prescription medicine contains 300 or 500 U of botulinum toxin, distributed by Galderma Australia Pty Ltd, North Sydney, NSW, for the treatment of frown lines and crow’s feet around the eyes. Dysport® lasts up to 6 months and further courses of treatment may be necessary. It should only be administered by trained medical professionals. Dysport® has risks and benefits. Ask your healthcare professional if Dysport® is right for you and to explain the possible side effects. Tell them if any side effects concern you. ALWAYS FOLLOW THE INSTRUCTIONS YOU ARE GIVEN. For details on precautions and side effects, see the Consumer Medicines Information at www.medsafe.govt.nz or consult your healthcare professional. Unfunded for aesthetic indications. Product and treatment costs apply. Galderma Australia Pty Ltd, Level 18, 1 Denison St, North Sydney, NSW 2060, Australia. ABN 12 003 976 930. Distributed in NZ by Healthcare Logistics, 58 Richard Pearse Drive, Airport Oaks, Mangere 2022, Auckland. For more information please phone 0800 822 310. Dysport® is a registered trademark of Ipsen Pty Ltd. Galderma is a registered trademark of Galderma Holding S.A
Radiesse® (+) Lidocaine injectable implant is intended for plastic and reconstructive surgery, including deep dermal and sub-dermal soft tissue augmentation of the facial area and dorsum of the hands in adults. Radiesse® (+) Lidocaine injectable implant is indicated for: the treatment of nasolabial folds, marionette lines and jawline; the augmentation of cheeks; hand augmentation to correct volume loss in the dorsum of the hands; the restoration and/or correction of the signs of fat or volume loss (lipoatrophy) in the facial area and for rejuvenation of the hands fat loss (lipoatrophy) in people with human immunodeficiency virus. Radiesse® (+) Lidocaine should not be used on patients: with known hypersensitivity to any of the components or severe allergies including history of anaphylaxis; prone to inflammatory skin conditions, hypertrophic scars/keloids or poor wound healing; with bleeding disorders or inflamed/infected skin; in the presence of foreign bodies/implants; in the epidermis, glabellar or nose; taking anti-coagulants; in pregnancy or lactation; others. Please review the Radiesse® (+) Lidocaine Instructions for Use before prescribing for full safety information. These are available from Merz Australia on 1800 268 820 or https://merzaustra lia.com.au/products/ This medical device must be administered by a Healthcare Professional.
For information about how Merz handle personal data, please see Merz General Data Protection Information Notice at www.merz.com/fin
Copyright ©2023. Merz Australia Pty Ltd. All rights reserved. Radiesse® and Merz Aesthetics® are registered trademarks of Merz Pharma GMbH & Co. KGaA.
New Zealand: Pharmacy Retailing NZ Limited t/a Healthcare Logistics (HCL). 58 Richard Pearse Drive, Mangere, Auckland 2022. For more information please phone 0800 822 310.
MINT MONO® threads are smooth monofilament stimulating threads, pre-threaded onto a 29 Gauge needle . They are made from PDO (polydiaxanone) Material which has been used in surgery as a suture material for over 30 years. These threads are placed in the superficial subcutaneous dermal layer of the skin. They support the formation of new collagen and helps support skin firmness and elasticity. MINT MONO threads are completely absorbed by the body in about 3-4 months after treatment.
MINT MONO threads are versatile and can be used in many areas across the face and body. Treatment areas include; neck and décolletage, the face – nasolabial lines, marionette lines, upper cheeks, jowl area, crow’s feet, vermillion border, eye area, crepey skin, as well as the body: elbows, knees, upper arms, thighs, loose abdominal skin, buttocks
There are a number of possible side effects associated with MINT MONO. These side effects include but are not limited to; patients should anticipate bruising with this treatment, redness for several hours following treatment, pain and discomfort throughout the procedure and patients may experience some discomfort for several days afterwards as the threads settle, localised swelling can occur after the treatment, however this should settle in 24 hours after the treatment.
All medicines, medical devices and treatments carry benefits and risks. Individual results may vary.
PDO Threads are classified as Class II devices and can only be FDA cleared.
Meridus Medical Europe Limited – Unit 3D, North Point House, North point Business Park, New Mallow Rd, CORK, Ireland
Australian Sponser. HansBiomed Australia Pty Ltd. – PO Box 339, Cyrrumbin Waters, QLD. 4223 Aus.
TCA Touch is a Prescription Medicine which contains a 30% strength of Trichloroacetic acid (TCA). There are risks and benefits associated with the use of TCA.
Precautions should be taken with this product and should only be administered by a medical
professional. Careful consultation prior to treatment should be considered to assess suitability.
Aftercare instructions should be followed, side effects are not limited to but include; redness, inflammation, sensitivity, peeling, swelling. Speak with your medical professional to determine if this product is right for you and to understand all the potential risks, side effects and benefits.
TCA is not funded for aesthetic purposes. You will need to pay the full cost of this medicine. (pHformula New Zealand – Boutique Beauty
Brands Napier NZ)
Dermapen® is a medical device. All medical device treatments carry risks and benefits. It may not be appropriate for everyone. Your trained technician will advise if this treatment is right for you and if so, the possible side effects you should be aware of. Individual results may vary.
TAPS NP20655 March 2024
Cornerstone Building
15 Sala Street
Rotorua
Phone Haly
027 335 3403
